| scholarly article | Q13442814 |
| P356 | DOI | 10.1136/BMJ.E3821 |
| P8608 | Fatcat ID | release_pm2jtwoigbcodjlddvvncxackm |
| P698 | PubMed publication ID | 22700787 |
| P50 | author | Manuel Ramos-casals | Q42646201 |
| Pilar Brito Zerón | Q56956066 | ||
| Antoni Sisó-Almirall | Q79788945 | ||
| P2093 | author name string | Xavier Bosch | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e3821 | |
| P577 | publication date | 2012-06-14 | |
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | Primary Sjogren syndrome | |
| P478 | volume | 344 |
| Q33627160 | A case report of Sjögren syndrome manifesting bilateral basal ganglia lesions |
| Q92048255 | A regulatory role for CD72 expression on B cells and increased soluble CD72 in primary Sjogren's syndrome |
| Q39828419 | A validated method of labial minor salivary gland biopsy for the diagnosis of Sjögren's syndrome |
| Q36254489 | Acupuncture for Primary Sjögren Syndrome (pSS) on symptomatic improvements: study protocol for a randomized controlled trial |
| Q38170245 | Annular erythema in primary Sjogren's syndrome: description of 43 non-Asian cases. |
| Q92239383 | Articular and Peripheral Nervous System Involvement Are Linked to the Long-Term Outcome in Primary Sjögren's Syndrome: The Relevance of Single Organ Manifestations Rather Than a Composite Score as Predictors |
| Q90134348 | Association between comorbidities and extraglandular manifestations in primary Sjögren's syndrome: a multicenter cross-sectional study |
| Q64069388 | Brachial plexopathy with Sjögren syndrome |
| Q57057058 | Cerebral Large-Vessel Vasculitis in Sjogren's Syndrome: Utility of High-Resolution Magnetic Resonance Vessel Wall Imaging |
| Q33568158 | Characterization and risk estimate of cancer in patients with primary Sjögren syndrome |
| Q26800693 | Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements |
| Q49131251 | Cholinergic anti-inflammatory pathway in the non-obese diabetic mouse model |
| Q58581640 | Clinical features and potential relevant factors of renal involvement in primary Sjögren's syndrome |
| Q54996887 | Clinical features and risk factors of neurological involvement in Sjögren's syndrome. |
| Q37566464 | Comparative Proteomics of Mouse Tears and Saliva: Evidence from Large Protein Families for Functional Adaptation |
| Q40785165 | Cryoglobulinaemic vasculitis at diagnosis predicts mortality in primary Sjögren syndrome: analysis of 515 patients |
| Q35906036 | Diagnosis of Liver Involvement in Primary Sjögren Syndrome |
| Q48193607 | Down-regulation of increased TRAF6 expression in the peripheral mononuclear cells of patients with primary Sjögren's syndrome by an EBV-EBER1-specific synthetic single-stranded complementary DNA molecule. |
| Q38190588 | EBV and other viruses as triggers of tertiary lymphoid structures in primary Sjögren's syndrome. |
| Q38675817 | Early diagnosis of primary Sjögren's syndrome: EULAR-SS task force clinical recommendations |
| Q47886685 | Effects of periodontal treatment on primary sjȫgren's syndrome symptoms. |
| Q64093212 | Elevated / Expression During the Disease Process of Primary Sjögren's Syndrome |
| Q50574335 | Endogenous event-related potentials in patients with primary Sjögren's syndrome without central nervous system involvement. |
| Q37461917 | Epigenetic Signatures of Salivary Gland Inflammation in Sjögren's Syndrome |
| Q92314007 | Epithelial Cell Adhesion Molecule in Primary Sjögren's Syndrome Patients: Characterization and Evaluation of a Potential Biomarker |
| Q36060723 | How hepatitis C virus modifies the immunological profile of Sjögren syndrome: analysis of 783 patients |
| Q55283251 | How to Distinguish Patients with pSS among Individuals with Dryness without Invasive Diagnostic Studies. |
| Q59125538 | IFI16 filament formation in salivary epithelial cells shapes the anti-IFI16 immune response in Sjögren's syndrome |
| Q35510902 | In vivo confocal scanning laser microscopy in patients with primary Sjögren's syndrome: A monocentric experience |
| Q36538934 | Increased IL-21 Expression Induces Granzyme B in Peripheral CD5(+) B Cells as a Potential Counter-Regulatory Effect in Primary Sjögren's Syndrome |
| Q30579328 | Increased utilisation of eye disorder-related ambulatory medical services prior to the diagnosis of Sjögren's syndrome in female patients: a longitudinal population-based study in Taiwan. |
| Q41540895 | Interdisciplinary, Comprehensive Oral and Ocular Evaluation of Patients with Primary Sjögren's Syndrome |
| Q47957728 | Is YouTube useful as a source of information for Sjögren's syndrome? |
| Q33667694 | Is hydroxychloroquine effective in treating primary Sjogren's syndrome: a systematic review and meta-analysis |
| Q92188841 | JAK Inhibitors and Oxidative Stress Control |
| Q39223579 | Liposomal local therapy as treatment for sicca symptoms in patients with primary Sjögren's syndrome |
| Q62398515 | Longitudinal analysis of tear cathepsin S activity levels in male non-obese diabetic mice suggests its potential as an early stage biomarker of Sjögren's Syndrome |
| Q55396788 | NUDT15 R139C variation increases the risk of azathioprine-induced toxicity in Chinese subjects: Case report and literature review. |
| Q34650103 | Novel aspects of Sjögren's syndrome in 2012. |
| Q38096005 | Oral manifestations and their treatment in Sjögren's syndrome |
| Q47567628 | Patient reported outcomes of the -clinical use of a proprietary topical dry mouth product |
| Q55347459 | Patients with chronic periodontitis present increased risk for primary Sjögren syndrome: a nationwide population-based cohort study. |
| Q38107925 | Primary Sjogren's syndrome and malignancy risk: a systematic review and meta-analysis |
| Q36152109 | Primary Sjögren syndrome in Han Chinese: clinical and immunological characteristics of 483 patients |
| Q38076460 | Primary Sjögren syndrome: an update on current pharmacotherapy options and future directions. |
| Q28069521 | Primary Sjögren's syndrome accompanied by pleural effusion: a case report and literature review |
| Q48341665 | Primary Sjögren's syndrome: Extraglandular manifestations and hydroxychloroquine therapy. |
| Q87153845 | Pulmonary Langerhans Histiocytosis: an uncommon cause of interstitial pneumonia in a patient with Sjögren syndrome |
| Q99238314 | Recent Advances in the Use of Exosomes in Sjögren's Syndrome |
| Q38633492 | Renal involvement in primary Sjögren syndrome |
| Q38526786 | Renal involvement in primary Sjögren's syndrome |
| Q30239053 | Sjögren Syndrome and Pregnancy: A Literature Review |
| Q55970262 | Sjögren syndrome |
| Q36228694 | Subjective and Objective Measures of Dryness Symptoms in Primary Sjögren's Syndrome - Capturing the discrepancy |
| Q49712793 | Survey of Ophthalmologists Regarding Practice Patterns for Dry Eye and Sjogren Syndrome |
| Q48249597 | Systemic activity and mortality in primary Sjögren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients |
| Q98726977 | The challenge of managing comorbidities: a case report of primary Sjogren's syndrome in a patient with acute intermittent porphyria |
| Q50901646 | The clinical and laboratory characteristics of Sjögren's syndrome that progresses to systemic lupus erythematosus: a retrospective case-control study. |
| Q38118108 | The role of viruses in autoreactive B cell activation within tertiary lymphoid structures in autoimmune diseases |
| Q38795404 | Treating the Underlying Pathophysiology of Primary Sjögren Syndrome: Recent Advances and Future Prospects |
| Q56882317 | Vasculitic neuropathies |
| Q90793796 | [Primary Sjögren's Syndrome - News on Diagnostics and Therapy] |
Search more.